John Bui
About John Bui
John Bui is a scientist with extensive experience in immunology, currently serving as a Senior Associate Scientist and Scientist at Sonoma Biotherapeutics in the Greater Seattle Area. His career spans over two decades in both academic and industry settings, including significant roles at Celgene, Juno Therapeutics, and Novo Nordisk.
Work at Sonoma BioTherapeutics
John Bui has been employed at Sonoma Biotherapeutics since 2020, where he serves as a Senior Associate Scientist. In this role, he contributes to the company's research initiatives in the Greater Seattle Area. Additionally, he has held the position of Scientist at Sonoma Biotherapeutics since 2021. His work focuses on advancing the company's goals in immunology and therapeutic development.
Previous Experience in Immunology Research
Prior to his current role, John Bui worked at Celgene as a Senior Associate Scientist in Immuno Oncology and Cellular Therapy from 2015 to 2020. He also held a position at Juno Therapeutics as a Senior Research Associate in Process and Analytical Development for one month in 2014. His earlier experience includes a three-year tenure at Novo Nordisk, where he worked as a Senior Research Associate in Cellular Immunology, following a two-year role as a Research Associate in the same field.
Background in Research and Development
John Bui's research career began at Fred Hutch, where he worked as a Research Technician I in the Julie McElrath HIV Lab from 1999 to 2004 and later as a Research Technician III in HVTN R&D from 2005 to 2009. He also gained experience at Benaroya Research Institute as a Research Technician II in the Bill Kwok Lab from 2003 to 2005. This extensive background has provided him with a solid foundation in immunology and cellular biology.
Education and Expertise
John Bui earned a Bachelor of Science (B.S.) degree in Cell/Cellular and Molecular Biology from the University of Washington, where he studied from 1997 to 2002. His educational background complements his extensive experience in immunology research, particularly in flow cytometry and assay development. He has worked with diverse immune cells and has been involved in both early discovery and clinical research programs.